After administering a PRN medication, when should you evaluate and document the outcome?

After administering a PRN medication, when should you evaluate and document the outcome?

• A. Evaluate after 30-60 minutes and document the outcome.
• B. Evaluate after 24 hours.
• C. No documentation is needed.
• D. Document before administration.

Answer: (A)

When a PRN medication is given, you assess its effect within the time frame you’d expect it to take action and then document what happened. For many PRN meds, that window is about 30–60 minutes after administration. This lets you determine if the symptom relief occurred and whether there were any adverse effects, so you can decide if another dose, a different intervention, or notifying a clinician is needed. Documentation after this evaluation provides a precise record of what was given, when, how the patient responded, and any side effects—critical for safety and continuity of care. Waiting 24 hours is too late to confirm effectiveness or catch issues early, and documenting before administration wouldn’t capture the outcome.

When a PRN medication is given, you assess its effect within the time frame you’d expect it to take action and then document what happened. For many PRN meds, that window is about 30–60 minutes after administration. This lets you determine if the symptom relief occurred and whether there were any adverse effects, so you can decide if another dose, a different intervention, or notifying a clinician is needed. Documentation after this evaluation provides a precise record of what was given, when, how the patient responded, and any side effects—critical for safety and continuity of care. Waiting 24 hours is too late to confirm effectiveness or catch issues early, and documenting before administration wouldn’t capture the outcome.